Both in Pharmaceuticals
Elanco Animal Health Incorporated vs Protagonist Therapeutics
Over the past year ELAN returned +4.1% and PTGX returned +84.2%; their daily moves had a correlation of 0.23.
ELAN +4.1% PTGX +84.2%Growth of $1, one year, split-adjusted
| Metric | ELAN | PTGX |
|---|---|---|
| Price | $23.06 | $144.85 |
| Market cap | $11.52B | $9.37B |
| Today | −0.77% | +0.35% |
| 1 month | +5.9% | +4.1% |
| 6 months | +2.4% | +47.3% |
| Year to date | +1.9% | +65.8% |
| 1 year | +2.1% | +88.9% |
| Revenue growth (YoY) | +10.2% | +3749.2% |
| Gross margin | 58.3% | 100.0% |
| Net margin | 3.9% | 76.3% |
| P/E (TTM) | — | 113.1× |
| Price / sales | 2.3× | 33.2× |
| Net cash | -$3.39B | $782.6M |
| Dividend yield | — | — |
| Volatility (60d) | 34.2% | 31.3% |
| Short % of float | 6.3% | 16.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).